Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma
Sponsor: Corvus Pharmaceuticals, Inc.
Summary
This is a Phase 1/1b, open-label, first in human study of CPI-818, an oral interleukin-2-inducible tyrosine kinase (ITK) inhibitor for the treatment of relapsed/refractory (R/R) T-cell lymphoma.. This trial will study the safety, tolerability, and anti-tumor activity of CPI-818 as a single drug.
Official title: A Phase 1/1b Dose-Escalation Trial Evaluating CPI-818, an Oral Interleukin-2-Inducible T-Cell Kinase Inhibitor, in Subjects With Relapsed/Refractory T-Cell Lymphoma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
151
Start Date
2019-05-03
Completion Date
2026-04-30
Last Updated
2025-04-16
Healthy Volunteers
No
Conditions
Interventions
CPI-818
Interleukin-2 inducible T-cell Kinase Inhibitor
Locations (22)
Stanford University
Palo Alto, California, United States
University of Michigan
Ann Arbor, Michigan, United States
Washington University
St Louis, Missouri, United States
Hackensack University Medical Center
Hackensack, New Jersey, United States
Ohio State University
Columbus, Ohio, United States
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Concord Repatriation General Hospital
Concord, New South Wales, Australia
Liverpool Hospital
Liverpool, New South Wales, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Epworth Healthcare
Melbourne, Victoria, Australia
Beijing Friendship Hospital
Beijing, Beijing Municipality, China
Beijing Boren Hospital
Beijing, Beijing Municipality, China
Beijing Cancer Hospital
Beijing, Beijing Municipality, China
Shanghai East Hospital
Pudong, Shanghai Municipality, China
Henan Cancer Hospital
Henan, Zhengzhou, China
Seoul National University Hospital
Seoul, Gyeonggido, South Korea
Asan Medical Center
Seoul, Gyeonggido, South Korea
Samsung Medical Center
Seoul, Gyeonggido, South Korea
Seoul St. Mary's Hospital
Seoul, Gyeonggido, South Korea
Inje University Busan-Paik Hospital
Busan, South Korea
Pusan National University Hospital
Busan, South Korea
Gachon University
Incheon, South Korea